Strategic Partnerships Leverage RightEye’s FDA Breakthrough Designation history and MIT collaboration to position joint innovation opportunities with medtech firms, research centers, and health systems seeking validated eye-tracking biomarkers and sensorimotor assessments.

Healthcare Expansion Target vision and neurology clinics, ophthalmology groups, and general health systems for automated sensorimotor exams and objective eye-tracking diagnostics that can improve early detection of vision and neurological conditions.

Sports Performance Engage professional and collegiate teams and sports performance programs to expand adoption of eye-tracking analytics for training, scouting, and injury prevention, highlighting measurable performance improvements.

Metaverse UX Capitalize on partnerships with metaverse hardware developers and content platforms to optimize user interfaces, accessibility, and engagement metrics through rich eye-tracking data and usability insights.

Strategic Growth Position RightEye as a data-rich, clinically credible platform with ongoing updates and a strong funding profile to attract customers seeking scalable, interoperable solutions and long-term vendor stability.